BIOMAT Database Logo BIOMAT Database Logo

Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. 1996

I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

Familial multiple endocrine neoplasia type 1 is an autosomal dominant hereditary disorder characterized by multiple parathyroid, pancreatic, duodenal, and pituitary tumors. The parathyroid tumors may arise as diffuse areas of hyperplasia, whereas the pancreatic and duodenal tumors usually form as discrete nodules. Except for a single report, tumor loss of heterozygosity (LOH) mapping of the putative MEN1 suppressor gene on chromosome 11q13 in the past has been restricted by analysis of a single tumor from individual patients and somatic cellular contamination. For this reason, it has not been possible to analyze the clonality of the emerging MEN1 neoplasms. Furthermore, it has been previously unknown whether the LOH pattern varies between individual MEN1 tumors in a given patient or among tumors of different histological origins within unrelated patients. To address these previous limitations, the present study introduces a refinement in microdissection in which endothelial cells are stained and selectively excluded. Tissue microdissection was applied to study LOH patterns on chromosome 11q13 using 8 polymorphic DNA markers in 44 different MEN1 tumors from parathyroid, pancreas, and duodenum in nine unrelated patients. In addition, X-chromosome inactivation clonal analysis was applied to 16 individual microdissected regions from seven parathyroid glands in three female patients. The LOH rates of parathyroid lesions (100%) and endocrine tumors of the pancreas (83%) were strikingly different from the LOH rate of gastrinomas (21%), suggesting that the mechanism that drives LOH may be influenced by the tissue context. Moreover, combined LOH and X-chromosome inactivation scoring of the same microdissected region revealed that parathyroid MEN1 neoplasms can consist of more than one clone. In this study, the centromeric boundary of the putative MEN1 gene was PYGM. Analysis of differential LOH patterns in multiple microdissected tumors in the same patient constitutes a novel approach to suppressor gene mapping.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions
D018761 Multiple Endocrine Neoplasia Type 1 A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). Neoplasia, Multiple Endocrine Type 1,Neoplasms, Multiple Endocrine Type 1,Wermer Syndrome,Multiple Endocrine Neoplasia Type I,Multiple Endocrine Neoplasms Type 1,Neoplasms, Multiple Endocrine Type I

Related Publications

I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.
March 2001, The Journal of clinical endocrinology and metabolism,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors.
January 1995, Genes, chromosomes & cancer,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
[Allelic loss on chromosome 11q13 in male breast cancer].
January 1995, Anales de la Real Academia Nacional de Medicina,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
A transcript map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.
June 1997, Genomics,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
July 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
A 1.5-megabase physical map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.
December 1996, Genomics,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
December 1994, Cancer research,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.
March 1990, Proceedings of the National Academy of Sciences of the United States of America,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
February 1999, The Journal of clinical endocrinology and metabolism,
I A Lubensky, and L V Debelenko, and Z Zhuang, and M R Emmert-Buck, and Q Dong, and S Chandrasekharappa, and S C Guru, and P Manickam, and S E Olufemi, and S J Marx, and A M Spiegel, and F S Collins, and L A Liotta
Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
August 1997, Genomics,
Copied contents to your clipboard!